Calogero A E, Bagdy G, Szemeredi K, Tartaglia M E, Gold P W, Chrousos G P
Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.
Endocrinology. 1990 Apr;126(4):1888-94. doi: 10.1210/endo-126-4-1888.
A substantial body of experimental evidence indicates that serotonin (5-HT) and several synthetic 5-HT receptor agonists activate the hypothalamic-pituitary-adrenal (HPA) axis. To explore the mechanism(s) by which 5-HT or 5-HT agonists enhance the activity of the HPA axis in vitro, we examined the stimulatory effects of the 5-HT1a agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), the 5-HT1c/5-HT1b agonist m-chlorophenylpiperazine (m-CPP), and the 5-HT2/5-HT1c agonist 1-(2,5-dimethoxy-4-iodophenyl)2-amino-propane (DOI) on plasma ACTH and corticosterone secretion in the rat. To test whether 8-OH-DPAT, m-CPP, or DOI increase plasma ACTH levels by stimulating the release of endogenous CRH, catheterized conscious male Sprague-Dawley rats were pretreated with hyperimmune CRH rabbit serum (TS-6) or normal rabbit serum and subsequently challenged with a maximally stimulatory dose of the above 5-HT agonists. Pretreatment with TS-6 completely suppressed the ACTH response to m-CPP and significantly blunted the responses to 8-OH-DPAT or DOI. To examine whether the remaining ACTH response to 8-OH-DPAT or DOI was also mediated by a pituitary site of action, we administered each of these agents to pituitary stalk-transected or sham-operated rats. The ACTH responses to 8-OH-DPAT and DOI in stalk-transected rats were preserved, although significantly blunted, compared to those in sham-operated rats. This suggested that both of these 5-HT agonists may also act at the pituitary level to stimulate ACTH release in vivo. Although the ACTH responses to 8-OH-DPAT, m-CPP, and DOI were blunted after both TS-6 pretreatment and pituitary stalk transection, corticosterone responses were only slightly affected, suggesting that some of these compounds may cause corticosterone release in the rat through another mechanism. To evaluate this hypothesis, ACTH and corticosterone responses to 8-OH-DPAT, m-CPP, and DOI were examined in rats whose HPA axis had been suppressed by a single high dose injection of dexamethasone. The corticosterone responses to 8-OH-DPAT and DOI were blunted compared to those of saline-pretreated rats, but were inappropriately high compared to the ACTH responses observed in these rats. On the other hand, both ACTH and corticosterone responses to m-CPP were completely abolished by dexamethasone.(ABSTRACT TRUNCATED AT 400 WORDS)
大量实验证据表明,血清素(5-羟色胺,5-HT)和几种合成的5-HT受体激动剂可激活下丘脑-垂体-肾上腺(HPA)轴。为了探究5-HT或5-HT激动剂在体外增强HPA轴活性的机制,我们检测了5-HT1a激动剂8-羟基-2-(二正丙基氨基)四氢萘(8-OH-DPAT)、5-HT1c/5-HT1b激动剂间氯苯哌嗪(m-CPP)以及5-HT2/5-HT1c激动剂1-(2,5-二甲氧基-4-碘苯基)-2-氨基丙烷(DOI)对大鼠血浆促肾上腺皮质激素(ACTH)和皮质酮分泌的刺激作用。为了检测8-OH-DPAT、m-CPP或DOI是否通过刺激内源性促肾上腺皮质激素释放激素(CRH)的释放来提高血浆ACTH水平,将经导管插入的清醒雄性斯普拉格-道利大鼠用超免疫CRH兔血清(TS-6)或正常兔血清进行预处理,随后用上述5-HT激动剂的最大刺激剂量进行激发。用TS-6预处理可完全抑制对m-CPP的ACTH反应,并显著减弱对8-OH-DPAT或DOI的反应。为了研究对8-OH-DPAT或DOI剩余的ACTH反应是否也由垂体作用位点介导,我们将这些药物分别给予垂体柄横断或假手术的大鼠。与假手术大鼠相比,垂体柄横断大鼠对8-OH-DPAT和DOI的ACTH反应得以保留,尽管明显减弱。这表明这两种5-HT激动剂在体内也可能作用于垂体水平以刺激ACTH释放。尽管在TS-6预处理和垂体柄横断后,对8-OH-DPAT、m-CPP和DOI的ACTH反应均减弱,但皮质酮反应仅受到轻微影响,这表明这些化合物中的一些可能通过另一种机制导致大鼠体内皮质酮释放。为了评估这一假设,我们检测了在HPA轴已被单次高剂量地塞米松注射抑制的大鼠中,对8-OH-DPAT、m-CPP和DOI的ACTH和皮质酮反应。与生理盐水预处理的大鼠相比,对8-OH-DPAT和DOI的皮质酮反应减弱,但与这些大鼠中观察到的ACTH反应相比却异常高。另一方面,地塞米松完全消除了对m-CPP的ACTH和皮质酮反应。(摘要截断于400字)